Symptomatic Improvement in Irritable Bowel Syndrome With Oral Ketamine.

Omar Dyara, Natasha Topoluk, Harvey J Woehlck
{"title":"Symptomatic Improvement in Irritable Bowel Syndrome With Oral Ketamine.","authors":"Omar Dyara, Natasha Topoluk, Harvey J Woehlck","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Irritable bowel syndrome (IBS) often is treated as a partially diet-responsive functional bowel disorder. Few interventions have been found to be effective in diet-refractory IBS, leading to lifestyle disruptions due to persistent symptoms. The efficacy of low-dose home ketamine therapy suggests others may benefit.</p><p><strong>Case presentation: </strong>A female patient in her 60s with progressive presumed IBS with diarrhea found diet-based treatments ineffective, resulting in severe lifestyle disruptions. After a hysterectomy, intolerance to opioids for postoperative pain prompted the use of intravenous ketamine. An unexpected and prolonged improvement in IBS symptoms resulted. The patient sought continued treatment with ketamine for IBS symptoms and experienced continued symptomatic relief with 20 mg oral ketamine every 2 weeks at home.</p><p><strong>Discussion: </strong>No other published cases of ketamine for IBS were found.</p><p><strong>Conclusions: </strong>While dietary changes remain the gold standard for IBS, this patient experience highlights ketamine as a potential adjunct therapy.</p>","PeriodicalId":94268,"journal":{"name":"WMJ : official publication of the State Medical Society of Wisconsin","volume":"123 5","pages":"384-386"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"WMJ : official publication of the State Medical Society of Wisconsin","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Irritable bowel syndrome (IBS) often is treated as a partially diet-responsive functional bowel disorder. Few interventions have been found to be effective in diet-refractory IBS, leading to lifestyle disruptions due to persistent symptoms. The efficacy of low-dose home ketamine therapy suggests others may benefit.

Case presentation: A female patient in her 60s with progressive presumed IBS with diarrhea found diet-based treatments ineffective, resulting in severe lifestyle disruptions. After a hysterectomy, intolerance to opioids for postoperative pain prompted the use of intravenous ketamine. An unexpected and prolonged improvement in IBS symptoms resulted. The patient sought continued treatment with ketamine for IBS symptoms and experienced continued symptomatic relief with 20 mg oral ketamine every 2 weeks at home.

Discussion: No other published cases of ketamine for IBS were found.

Conclusions: While dietary changes remain the gold standard for IBS, this patient experience highlights ketamine as a potential adjunct therapy.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
口服氯胺酮可改善肠易激综合征的症状
导言:肠易激综合征(IBS)通常被视为一种对饮食有部分反应的功能性肠道疾病。很少有干预措施对饮食难治性肠易激综合征有效,这导致患者因症状持续存在而影响生活方式。低剂量家庭氯胺酮疗法的疗效表明,其他人也可能从中受益:一位 60 多岁的女性患者患有进行性推测肠易激综合征并伴有腹泻,但发现基于饮食的治疗无效,导致生活方式受到严重影响。子宫切除术后,由于不耐受阿片类药物的术后疼痛,她开始静脉注射氯胺酮。结果,肠易激综合征症状得到了意想不到的长期改善。患者寻求继续使用氯胺酮治疗肠易激综合征症状,每两周在家中口服20毫克氯胺酮,症状得到持续缓解:讨论:没有发现其他公开发表的氯胺酮治疗肠易激综合征的病例:结论:虽然改变饮食仍然是治疗肠易激综合征的黄金标准,但该患者的经历突出表明氯胺酮是一种潜在的辅助疗法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Development of Cervical Cancer Prevention Workshops for Hmong and Karenni Women Through a Community-Academic Partnership. Diary of an Orphaned Resident. Elsberg Syndrome: An Overlooked But Treatable Cause of Back Pain. Emergency Department Door to Discharge Times. Endocrine Abnormalities in Mosaic Trisomy 16 Adolescent: A Case Report.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1